StockData
PAVmed Inc. logo

PAVmed Inc. (PAVM) stock

PAVMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$1.51−0.24 (-13.71%)

Close on Nov 17, 2026Market cap $12.07MP/E –Yield –

PAVmed enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

PAVmed's enterprise value was -$9.46M on Nov 11, 2026, against -$4.59M a year earlier. Over the last 5 years it ranged from -$9.46M to $170.65M, with a median of $21.85M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026-$9.46M–
2025Dec 31, 2025-$8.01M-668.9%
2024Dec 31, 2024$1.41M-95.8%
2023Dec 29, 2023$33.90M+378.0%
2022Dec 30, 2022$7.09M-95.8%
2021Dec 31, 2021$170.65M+79.2%
2020Dec 31, 2020$95.21M+142.6%
2019Dec 31, 2019$39.25M+142.3%
2018Dec 31, 2018$16.20M-40.8%
2017Dec 29, 2017$27.38M-69.6%
2016Dec 30, 2016$90.05M–

More PAVmed figures

See a number that looks wrong?